Keyphrases
Liver Transplantation
100%
Liver Transplant Recipients
53%
Hepatitis C Virus
52%
Liver
40%
Hepatitis C Virus Infection
39%
Hepatitis B Virus Infection
38%
Hepatitis B Virus
37%
Israel
36%
Lamivudine
36%
Ischemia-reperfusion Injury
27%
Non-alcoholic Fatty Liver Disease (NAFLD)
27%
Cirrhosis
25%
Nonalcoholic Steatohepatitis
23%
Transplantation
22%
Chronic Hepatitis C
21%
Liver Biopsy
21%
Hepatocellular Carcinoma
20%
Hepatitis C Virus Genotypes
20%
Hepatitis B
20%
Hepatitis B Surface Antigen (HBsAg)
20%
Ribavirin
19%
Hepatitis B Virus DNA
19%
Chronic Liver Disease
17%
Direct-acting Antivirals
16%
Hepatic Injury
16%
Orthotopic Liver Transplantation
15%
Genotype 1
15%
Liver Disease
15%
SVR12
15%
Sustained Virological Response
15%
Fulminant Hepatic Failure
14%
Grazoprevir
14%
Lamivudine Resistance
13%
Recurrent Hepatitis
13%
Liver Fibrosis
13%
Ischemia
13%
Fibrosis
13%
Mouse Liver
12%
Interferon-α (IFN-α)
12%
Serum Hepatitis
12%
Israeli
12%
Primary Sclerosing Cholangitis
12%
Immune Response
11%
Hepatic Fibrosis
11%
Hepatitis E Virus
11%
Liver Allograft
11%
Advanced Fibrosis
10%
Confidence Interval
10%
Sofosbuvir
10%
Antiretroviral Therapy
10%
Pharmacology, Toxicology and Pharmaceutical Science
Hepatitis B Virus
48%
Hepatitis B
47%
Hepatitis C Virus
43%
Infection
42%
Lamivudine
37%
Hepatitis C
33%
Mouse
29%
Prevalence
28%
Reperfusion Injury
25%
Fibrosis
25%
Liver Fibrosis
24%
Chronic Hepatitis C
23%
Nonalcoholic Fatty Liver
22%
Antivirus Agent
22%
Ribavirin
21%
Liver Injury
21%
Hepatitis C Virus Genotype 1
20%
Liver Cirrhosis
20%
Adverse Event
19%
Ischemia
18%
Hepatitis B Antigen
18%
Caspase 3
17%
Placebo
16%
Grazoprevir
14%
Chronic Hepatitis B
13%
Virus DNA
13%
Liver Cell Carcinoma
13%
Injury
11%
Sofosbuvir
11%
Liver Disease
10%
Disease
10%
Chronic Liver Disease
10%
Liver Enzyme
10%
Liver Ischemia
10%
Antiviral Therapy
10%
Alanine Aminotransferase
10%
Hepatitis Delta Virus
9%
Fulminant Hepatic Failure
9%
Interferon
9%
Autoimmune Hepatitis
8%
Erythropoietin
8%
Ruzasvir
8%
Uprifosbuvir
8%
Recombinant Erythropoietin
8%
Receptor
8%
Virus RNA
7%
Tumor Necrosis Factor
7%
Lipopolysaccharide
6%
Fatty Liver
6%
Hepatitis B(e) Antigen
6%
Medicine and Dentistry
Liver Transplantation
83%
Hepatitis B
44%
Infection
37%
Hepatitis C Virus
37%
Hepatitis B Virus
36%
Lamivudine
31%
Liver Graft
28%
Nonalcoholic Fatty Liver
26%
Liver Disease
24%
Fibrosis
24%
Hepatitis C
23%
Liver Fibrosis
21%
Liver Cirrhosis
21%
Prevalence
20%
Disease
19%
Liver Biopsy
19%
Hepatocellular Carcinoma
18%
Chronic Hepatitis C
15%
Ribavirin
15%
Antiviral Therapy
14%
Chronic Liver Disease
13%
Liver Injury
12%
Cholestasis
12%
Transplantation
12%
Antivirus Agent
11%
Hepatitis B Antigen
11%
Primary Biliary Cirrhosis
10%
Chronic Hepatitis B
10%
Fulminant Hepatic Failure
10%
Virus DNA
10%
Liver Enzyme
9%
Primary Sclerosing Cholangitis
9%
Kidney Transplantation
9%
Hepatocyte
9%
Recurrent Disease
8%
Vein Occlusion
8%
Brain Disease
8%
Hepatitis C Virus Genotype 1
8%
Ascites
7%
Reperfusion Injury
7%
Hepatitis B(e) Antigen
7%
Programmed Cell Death
7%
Alkaline Phosphatase
7%
Adverse Event
7%
Alanine Aminotransferase
6%
Lipopolysaccharide
6%
Ischemia
6%
Fulminant
6%
Virus Infection
6%
Bilirubin
6%